Fig. 4From: Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolyticsAlgorithm for monitoring and treating patients for oral chemotherapy-induced cancer-therapy-related cardiac dysfunction (CTRCD)Back to article page